Cargando…
Rosiglitazone treatment and cardiovascular disease in the Veterans Affairs Diabetes Trial
AIMS: To evaluate the relationship between patterns of rosiglitazone use and cardiovascular (CV) outcomes in the Veterans Affairs Diabetes Trial (VADT). METHODS: Time-dependent survival analyses, case–control and 1 : 1 propensity matching approaches were used to examine the relationship between patt...
Autores principales: | Florez, H, Reaven, P D, Bahn, G, Moritz, T, Warren, S, Marks, J, Reda, D, Duckworth, W, Abraira, C, Hayward, R, Emanuele, N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676911/ https://www.ncbi.nlm.nih.gov/pubmed/25964070 http://dx.doi.org/10.1111/dom.12487 |
Ejemplares similares
-
Blood Pressure and Cardiovascular Disease Risk in the Veterans Affairs Diabetes Trial
por: Anderson, Robert J., et al.
Publicado: (2011) -
Observation on Renal Outcomes in the Veterans Affairs Diabetes Trial
por: Agrawal, Lily, et al.
Publicado: (2011) -
Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial
por: Davis, Stephen N., et al.
Publicado: (2019) -
Association of PAI-1 and Fibrinogen With Diabetic Retinopathy in the Veterans Affairs Diabetes Trial (VADT)
por: Azad, Nasrin, et al.
Publicado: (2014) -
Rates and Determinants of Coronary and Abdominal Aortic Artery Calcium Progression in the Veterans Affairs Diabetes Trial (VADT)
por: Saremi, Aramesh, et al.
Publicado: (2010)